SaraElizabethCosgroveMD
Infectious Disease • Baltimore, MDAssociate Professor of Medicine, Johns Hopkins University School of Medicine; Associate Hospital Epidemiologist, Director, Antimicrobial Stewardship Program
Are you Dr. Cosgrove?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 98 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287
Summary
- Dr. Sara Cosgrove, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Massachusetts. She is affiliated with Johns Hopkins Hospital and is an Associate Professor of Medicine at Director.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1998 - 2001
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Baylor College of MedicineClass of 1995
Certifications & Licensure
MD State Medical License 2001 - 2026
MA State Medical License 1998 - 2003- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.Dariusz A Hareza, Yehudit Bergman, Emily Jacobs, Jennifer Lu, Nancy D Hanson
Antimicrobial Agents and Chemotherapy. 2025-01-27 - Blood Culture Use in Medical and Surgical Intensive Care Units and Wards.Valeria Fabre, Yea-Jen Hsu, Karen C Carroll, Alejandra B Salinas, Avinash Gadala
JAMA Network Open. 2025-01-02 - How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?Kimberly C Claeys, Patricia J Simner, Tsigereda Tekle, Anthony D Harris, Emily Jacobs
Antimicrobial Agents and Chemotherapy. 2024-12-31
Press Mentions
Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial InfectionsNovember 21st, 2022- Tighter Controls on Antibiotics Promise to Curb Drug-ResistanceNovember 21st, 2022
- Maximizing Benefits and Minimizing Harms from Antibiotics: Scientific, Regulatory and Clinical Considerations by Dr. Sara Cosgrove November 8, 2022November 8th, 2022
- Join now to see all
